TownSquare Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

TownSquare Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,603	Closed	-$306K	–	443
2020 Q2	$306K	Sell	1,603 -1,064	-40%	-$220K	0.02%	331
2020 Q1	$571K	Sell	2,667 -748	-22%	-$161K	0.05%	253
2019 Q4	$707K	Buy	3,415 +33	+1%	+$6.1K	0.06%	229
2019 Q3	$622K	Buy	3,382 +40	+1%	+$6.55K	0.05%	258
2019 Q2	$576K	Sell	3,342 -407	-11%	-$48.3K	0.05%	239
2019 Q1	$442K	Buy	3,749 +988	+36%	+$99.6K	0.03%	289
2018 Q4	$279K	Buy	+2,761	New	+$280K	0.04%	301

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

TownSquare Capital's LKFT Position: Q3 2020 in Review

TownSquare Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 1,603 shares — an estimated $306K sold.

TownSquare Capital first reported a position in LKFT in Q4 2018 and held it in 7 quarters. The position peaked at $707K in Q4 2019. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

TownSquare Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
TownSquare Capital sold 1,603 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $306K.
TownSquare Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2018 and held it in 7 quarters.
TownSquare Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $707K in Q4 2019.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on TownSquare Capital's 13F filing for Q3 2020, filed 16 Nov 2020.